Carlo Farina

Summary

Affiliation: NiKem Research
Country: Italy

Publications

  1. ncbi Selective inhibition of osteoclast vacuolar H(+)-ATPase
    Carlo Farina
    NiKem Research S r l, Via Zambeletti 25, 20021 Baranzate di Bollate, Milan, Italy
    Curr Pharm Des 8:2033-48. 2002
  2. ncbi Synthesis of photoactivable inhibitors of osteoclast vacuolar ATPase
    Barbara Biasotti
    Dipartimento di Scienze Molecolari Agroalimentari, , Via Celoria 2, 20133 Milan, Italy
    Bioorg Med Chem 11:2247-54. 2003
  3. ncbi Effect of a novel vacuolar-H+-ATPase inhibitor on cell and tumor response to camptothecins
    Giovanna Petrangolini
    Istituto Nazionale Tumori, Via Venezian 1, 20133 Milan, Italy
    J Pharmacol Exp Ther 318:939-46. 2006
  4. ncbi Antimetastatic effect of a small-molecule vacuolar H+-ATPase inhibitor in in vitro and in vivo preclinical studies
    Rosanna Supino
    Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori, Via Venezian 1, 20133 Milan, Italy
    J Pharmacol Exp Ther 324:15-22. 2008
  5. ncbi Synthesis and biological evaluation of novel dimiracetam derivatives useful for the treatment of neuropathic pain
    Carlo Farina
    Brane Discovery, Insubrias BioPark, via Lepetit 34, 21040 Gerenzano, Varese, Italy
    Bioorg Med Chem 16:3224-32. 2008

Collaborators

  • S Gagliardi
  • Sabrina Dallavalle
  • Rosanna Supino
  • Giovanna Petrangolini
  • Laura Dal Bo
  • Anna Cleta Croce
  • Paola Misiano
  • Graziella Pratesi
  • Monica Tortoreto
  • Franco Zunino
  • Pietro Belfiore
  • Barbara Biasotti
  • Enrica Favini
  • Patrizia Casalini
  • Giovanni Bottiroli
  • Enrico Radaelli
  • Carlo Parini
  • Lucio Merlini

Detail Information

Publications5

  1. ncbi Selective inhibition of osteoclast vacuolar H(+)-ATPase
    Carlo Farina
    NiKem Research S r l, Via Zambeletti 25, 20021 Baranzate di Bollate, Milan, Italy
    Curr Pharm Des 8:2033-48. 2002
    ....
  2. ncbi Synthesis of photoactivable inhibitors of osteoclast vacuolar ATPase
    Barbara Biasotti
    Dipartimento di Scienze Molecolari Agroalimentari, , Via Celoria 2, 20133 Milan, Italy
    Bioorg Med Chem 11:2247-54. 2003
    ..The feasibility of introducing a radioactive 125I atom was ascertained by exchanging the iodine with a tributylstannyl group, that was again substituted by iodine...
  3. ncbi Effect of a novel vacuolar-H+-ATPase inhibitor on cell and tumor response to camptothecins
    Giovanna Petrangolini
    Istituto Nazionale Tumori, Via Venezian 1, 20133 Milan, Italy
    J Pharmacol Exp Ther 318:939-46. 2006
    ..Such findings support a potential interest for the use of vacuolar-H(+)-ATPase inhibitors in combination therapy to improve camptothecin efficacy...
  4. ncbi Antimetastatic effect of a small-molecule vacuolar H+-ATPase inhibitor in in vitro and in vivo preclinical studies
    Rosanna Supino
    Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori, Via Venezian 1, 20133 Milan, Italy
    J Pharmacol Exp Ther 324:15-22. 2008
    ....
  5. ncbi Synthesis and biological evaluation of novel dimiracetam derivatives useful for the treatment of neuropathic pain
    Carlo Farina
    Brane Discovery, Insubrias BioPark, via Lepetit 34, 21040 Gerenzano, Varese, Italy
    Bioorg Med Chem 16:3224-32. 2008
    ..These results suggest that compounds 5, 7 and 8 might represent novel and well-tolerated therapeutic agents for the relief of neuropathic pain...